Post job

Ariad Pharmaceuticals's revenue is $118.8 million.

What is Ariad Pharmaceuticals's revenue?

Ariad Pharmaceuticals's annual revenue is $118.8M. Zippia's data science team found the following key financial metrics about Ariad Pharmaceuticals after extensive research and analysis.
  • Ariad Pharmaceuticals has 380 employees, and the revenue per employee ratio is $312,632.
  • Ariad Pharmaceuticals peak revenue was $118.8M in 2024.

On this page

Peak revenue
$118.8M (2025)
Company peak revenue
Revenue / employee
$312,632
Company revenue / employee

Zippia finds jobs where you're a top candidate and applies on your behalf.

Floating question marks illustration
Peak revenue
$118.8M (2025)
Company peak revenue
Revenue / employee
$312,632
Company revenue / employee

Ariad Pharmaceuticals financing

Ariad Pharmaceuticals received early financing of $8.0M on 2001-11-01.

SeriesRound sizeDate
Post Ipo Equity$8M11/2001
Post Ipo Equity$6.1M11/2002
Post Ipo Equity$10M05/2003
Post Ipo Equity$41M10/2003
Post Ipo Equity$9.4M12/2003
Post Ipo Equity$14M10/2006

Ariad Pharmaceuticals investors

InvestorsSecurity type
Merlin BiomedPost Ipo Equity
CREDIT SUISSE GROUP AGPost Ipo Equity

Ariad Pharmaceuticals competitors

Ariad Pharmaceuticals's top competitor, Merck, earned an annual revenue of $64.2B.

Ariad Pharmaceuticals's smallest competitor is Astex Pharmaceuticals with revenue of $83.2M last year.

Ariad Pharmaceuticals revenue FAQs

Search for jobs

Zippia gives an in-depth look into the details of Ariad Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Ariad Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at Ariad Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Ariad Pharmaceuticals. The data presented on this page does not represent the view of Ariad Pharmaceuticals and its employees or that of Zippia.

Ariad Pharmaceuticals may also be known as or be related to ARIAD PHARMACEUTICALS INC, ARIAD Pharmaceuticals, ARIAD Pharmaceuticals, Inc., Ariad Pharmaceuticals, Ariad Pharmaceuticals Inc and Ariad Pharmaceuticals, Inc.